BANGALORE, India, Jan. 6, 2023 /PRNewswire/ -- The Global Cell Counting Market is Segmented by Type (Spectrophotometer, Cell Counter, Hemocytometer, Flow Cytometer, Hematology Analyzer), by Application (Pharmaceutical, Hospital, Research): Opportunity Analysis and Industry Forecast, 2022–2028. It is published in Valuates Reports under the Pharmaceuticals & Biotech Category.
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global Cell Counting market estimated at USD 8063.8 Million in the year 2022, is projected to reach a revised size of USD 10120 Million by 2028, growing at a CAGR of 3.9% during the forecast period 2022-2028
Major Factors Driving the Growth of Cell Counting Market
One of the reasons influencing the Cell Counting market expansion is the rising demand for biologics for the treatment of chronic diseases. The use of various cell counting tools during the development of biologics, including flow cytometers and spectrophotometers, helps manage the cell concentration in biologics and boosts the market's growth prospects.
COVID-19 had a significant effect on the Cell Counting market expansion. As lymphopenia and eosinopenia were possible COVID-19 indications, the adoption of cell counting instruments significantly increased during the pandemic.
Download Free Sample: https://reports.valuates.com/request/sample/QYRE-Othe-274/Global_Cell_Counting
TRENDS INFLUENCING THE GROWTH OF CELL COUNTING MARKET
The cell Counting market is anticipated to rise as hospital blood counts for illness diagnosis become more common. The patient's general health can be determined by looking at the patient's red blood cell count. A hemocytometer is a tool used in hospitals to count blood cells. Medical laboratory staff is under stress since the traditional methods of placing the smear under a microscope and manually counting the cells produce inaccurate findings. A computer-aided system will make it easier to get exact findings faster.
Increasing investment from the government and business, developing better image analysis tools, and improving informatics solutions will all lead to profitable Cell Counting market prospects. Global healthcare industries have seen tremendous expansion thanks to increased investments from both corporate and government entities. Due to the growth of infrastructure, large expenditures have made it possible for research facilities, educational institutions, hospitals, and other medical facilities to purchase the most recent technology in the cell counting field. It is anticipated that the industry will have tremendous potential opportunities due to the increasing inflow of expenditures for research.
The primary element fueling the Cell Counting market expansion is the rising incidence of AIDS and cancer among the world's population. Worldwide incidences of cancer and acquired immunodeficiency syndrome (AIDS) are on the rise, which has greatly boosted the demand for cell counts. Cell counting makes it easier to analyze intra-tumor heterogeneity, a crucial step in determining how quickly the cancer is spreading throughout the patient's body. The diagnosis and identification of primary tumors, metastatic tumors, and circulating cancers are all aided by cell counting. The identification of these malignancies is absolutely essential for the monitoring and therapeutic targeting processes that determine the course of additional treatment.
Numerous research fields, including neuroscience, cancer biology, and immunology, which have lucrative market expansion prospects, are increasingly using cell counting tools. Blood cell counting is essential for the evaluation of numerous diseases, and its usage is likely to rise throughout the forecast period, therefore the market is also expected to experience exponential growth. They are moreover widely employed in cancer research to control intra-tumor heterogeneity, which is crucial for figuring out how cancer progresses. For the purpose of disease monitoring and treatment targeting, cell counting is useful in identifying and classifying primary tumors, circulating tumors, and metastatic cancers.
View Full Report: https://reports.valuates.com/reports/QYRE-Auto-32H8584/china-cell-counting
CELL COUNTING MARKET SHARE
The hospital sector is anticipated to develop fastest. The primary drivers of the market growth include rising investments in pharmaceutical R&D, commercial expansion of several pharmaceutical companies, and rising regulatory approvals for cell culture-based vaccines. Due to the highly developed infrastructure facilities equipped with cutting-edge technologies, expanding numbers of AIDS and cancer patients rely heavily on hospitals and diagnostic laboratories for correct treatment as well as assessment.
By 2027, North America will account for the greatest market share. The market is expanding as a result of increased focus on biomedical, stem cell, and cancer research, as well as the rising incidence of chronic diseases including AIDS and cancer, the availability of an advanced healthcare sector, and government-initiated R&D efforts. Additionally, the region's expansion in the cell counting market has been aided by the widespread availability of important players and early acceptance of cell counting technologies.
Get Regional Report: https://reports.valuates.com/request/regional/QYRE-Othe-274/Global_Cell_Counting
Key Companies:
Get Chaptercost Report: https://reports.valuates.com/request/chaptercost/QYRE-Othe-274/Global_Cell_Counting
Buy Now for Single User + Covid-19 Impact :
https://reports.valuates.com/api/directpaytoken?rcode=QYRE-Othe-274&lic=single-user
SUBSCRIPTION
We have introduced a tailor-made subscription for our customers. Please leave a note in the Comment Section to know about our subscription plans.
SIMILAR REPORTS:
- Automated Cell Counters market size is estimated to be worth US$ 622.2 million in 2022 and is forecast to a readjusted size of US$ 918.1 million by 2028 with a CAGR of 6.7% during the review period.
- Organ-on-a-Chip market size is estimated to be worth US$ 80 million in 2022 and is forecast to a readjusted size of US$ 581.2 million by 2028 with a CAGR of 39.1% during the review period.
- Genomics market size is projected to reach USD 31240 Million by 2027, from USD 15120 Million in 2020, at a CAGR of 10.8%.
- Metagenomics market was valued at USD 176 Million in 2017 and is expected to reach USD 523 Million by 2024 at a CAGR of 16.8% from 2018 to 2024.
- Genomics Personalized Health market size is projected to reach USD 16780 Million by 2028, from USD 9232.4 Million in 2021, at a CAGR of 8.4% during 2022-2028.
- China Agrigenomics Market Report & Forecast 2021-2027
- CTMS Market size is projected to reach USD 2701.8 Million by 2027, from USD 1045 Million in 2020, at a CAGR of 14.5% during 2021-2027.
- Bioinformatics Services market size is projected to reach USD 2967.1 Million by 2027, from USD 1468.2 Million in 2020, at a CAGR of 10.1% during 2021-2027.
- Nutrigenomics market size is projected to reach USD 20990 Million by 2027, from USD 10770 Million in 2020, at a CAGR of 9.5% during 2021-2027.
- Biopreservation Market is projected to grow at a rate of 9.2% CAGR by 2026.
- Biopreservation Refrigerator Industry Research Report
- Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) market size is projected to reach USD 8514.8 Million by 2028, from USD 5180.8 Million in 2021, at a CAGR of 6.9% during 2022-2028.
- Laboratory Automation market size is projected to reach USD 5121.4 Million by 2028, from USD 3695.5 Million in 2021, at a CAGR of 4.3% during 2022-2028.
- Cell therapy market accounted for USD 7,754.89 Million in 2019, and is expected to reach USD 48,115.40 Million by 2027, registering a CAGR of 25.6% from 2020 to 2027.
- Laboratory Information Management System (LIMS) market size is projected to reach USD 1503.3 Million by 2028, from USD 889 Million in 2021, at a CAGR of 7.7% during 2022-2028.
- Tissue engineering market size was valued at USD 2374 Million in 2019 and is forecasted to reach a size of USD 6815 Million by 2027 at a CAGR of 14.2% from 2020 to 2027.
- Cell separation technologies market size was valued at USD 8,639.20 Million in 2019 and is projected to reach USD 28,766.14 Million by 2027, registering a CAGR of 15.4% from 2020 to 2027.
- Genetic testing market accounted for USD 12,682 Million in 2019, and is expected to reach USD 21,260 Million by 2027, registering a CAGR of 10.1% from 2020 to 2027.
- Bioinformatics Market Size is USD 8,614.29 Million in 2019, and is projected to reach USD 24,731.61 Million by 2027, growing at a CAGR of 13.4% from 2020 to 2027.
- Cell culture market accounted for USD 16,107.7 million in 2019 and is expected to reach USD 36,926.8 million by 2027, registering a CAGR of 10.9% from 2020 to 2027.
- Live Cell Imaging Market is anticipated to grow at the rate of 8.9% CAGR by 2027.
- Genome Editing market size is projected to reach USD 6739.8 Million by 2028, from USD 3513 Million in 2021, at a CAGR of 9.3% during 2022-2028.
- Cell Separation by Membrane Filtration Technology Market
Click here to see related reports on Cell Counting Market
ABOUT US:
Valuates offers in-depth market insights into various industries. Our extensive report repository is constantly updated to meet your changing industry analysis needs.
Our team of market analysts can help you select the best report covering your industry. We understand your niche region-specific requirements and that's why we offer customization of reports. With our customization in place, you can request any particular information from a report that meets your market analysis needs.
To achieve a consistent view of the market, data is gathered from various primary and secondary sources, at each step, data triangulation methodologies are applied to reduce deviance and find a consistent view of the market. Each sample we share contains a detailed research methodology employed to generate the report. Please also reach our sales team to get the complete list of our data sources.
CONTACT US:
Valuates Reports
[email protected]
For U.S. Toll-Free Call 1-(315)-215-3225
For IST Call +91-8040957137
WhatsApp: +91-9945648335
Website: https://reports.valuates.com
Twitter - https://twitter.com/valuatesreports
LinkedIn - https://in.linkedin.com/company/valuatesreports
Sitemap: https://reports.valuates.com/sitemap/html/reports/126
https://reports.valuates.com/sitemap/html/reports/127
https://rports.valuates.com/sitemap/html/reports/128
Logo: https://mma.prnewswire.com/media/1082232/Valuates_Reports_Logo.jpg
SOURCE Valuates Reports
![](https://rt.prnewswire.com/rt.gif?NewsItemId=IO79797&Transmission_Id=202301061100PR_NEWS_USPR_____IO79797&DateId=20230106)
Share this article